Lung Cancer | Breakfast with the Investigators: Current and Emerging Role of Antibody-Drug Conjugates in the Treatment of Lung Cancer
Research To Practice | Oncology Videos · Dr. Neil Love
July 8, 202459m 19s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Featuring perspectives from Dr Rebecca S Heist, Dr Luis Paz-Ares and Dr Jacob Sands, moderated by Dr Sands, including the following topics:
- Introduction (0:00)
- Integration of Antibody-Drug Conjugates (ADCs) into the Care of Patients with Non-Small Cell Lung Cancer (NSCLC) and HER2 Alterations — Dr Paz-Ares (1:28)
- Emerging Role of TROP2-Targeted ADCs for NSCLC — Dr Sands (23:12)
- Other Promising Targets for ADCs for Lung Cancer — Dr Heist (39:07)